ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,265, issued on May 13, was assigned to SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL Co. LTD. (Chengdu, China) and KLUS PHARMA INC..

"Antibody and use thereof" was invented by Haijun Tian (Cranbury, N.J.), Sujun Deng (Cranbury, N.J.), Chunxia Zhao (Cranbury, N.J.), Hong Li (Cranbury, N.J.), Dengnian Liu (Sichuan, China), Hu Long (Sichuan, China), Cheng Wang (Sichuan, China), Liang Xiao (Sichuan, China), Tongtong Xue (Sichuan, China) and Jingyi Wang (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, nucleic acid molecules for encoding the antibody and fragment,...